Apotex Corp. recalls
Apotex Corp. is named on 9 recalls in Recall Relay's records since November 2023, from FDA (15 recalled products: FDA lists each product as its own recall); the most recent was September 23, 2026.
All 15 recalled products, newest first.
-
Class IIofficial
Apotex Corp. recalls Paroxetine Extended-Release TabletsFailed dissolution specifications.
-
Class IIofficial
Apotex Corp. recalls Paxil CRFailed Dissolution Specifications; product failed to meet 24-month stability testing acceptance criteria
-
Class IIofficial
Apotex Corp. recalls Desmopressin Nasal SprayDefective container: defect in a batch of bottle caps, specifically involving dislodged or missing cap liners.
-
Class IIofficial
Apotex Corp. recalls Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution 0.2%/0.5%*Lack of Assurance of Sterility
-
Class IIofficial
Apotex Corp. recalls Ketorolac Tromethamine Ophthalmic SolutionLack of Assurance of Sterility; atypical weight loss due to improper bottle sealing leading to potential sterility concerns
-
Class IIofficial
Apotex Corp. recalls Brimonidine Tartrate/Timolol Maleate Ophthalmic SolutionLack of Assurance of Sterility; atypical weight loss due to improper bottle sealing leading to potential sterility concerns
-
Class IIofficial
Apotex Corp. recalls Brimonidine Tartrate/Timolol Maleate Ophthalmic SolutionLack of Assurance of Sterility
-
Class IIofficial
Apotex Corp. recalls Lacosamide Oral SolutionDefective Container: This recall is being initiated due to a leaking unit stored horizontally.
-
Class IIofficial
Apotex Corp. recalls Azelastine HCl Ophthalmic SolutionLack of Assurance of Sterility
-
Class IIofficial
Apotex Corp. recalls Ketorolac Tromethamine Ophthalmic SolutionLack of Assurance of Sterility
-
Class IIofficial
Apotex Corp. recalls Fluticasone Propionate Nasal Spray USP 50mcgCGMP Deviations: potential presence of Burkholderia cepacia complex
-
Class IIofficial
Apotex Corp. recalls Paroxetine Hydrochloride Tablets USPFailed Impurities/Degradation Specifications-Out of specification (OOS) results for the excipient Amadori Glucose adduct of Paroxetine
-
Class IIofficial
Apotex Corp. recalls Paroxetine Hydrochloride Tablets USPFailed Impurities/Degradation Specifications-Out of specification (OOS) results for the excipient Amadori Glucose adduct of Paroxetine
-
Class IIofficial
Apotex Corp. recalls Paroxetine Hydrochloride Tablets USPFailed Impurities/Degradation Specifications-Out of specification (OOS) results for the excipient Amadori Glucose adduct of Paroxetine
-
Class IIofficial
Apotex Corp. recalls Paroxetine Hydrochloride Tablets USPFailed Impurities/Degradation Specifications-Out of specification (OOS) results for the excipient Amadori Glucose adduct of Paroxetine
This page groups recalls by the company name the agency printed, so it can include different companies with similar names, and a recall may name a store or distributor rather than the maker. It counts the recalls in Recall Relay's records, not a company's whole history; an FDA recall that lists several products counts once. Open a recall to see its details and the agency's official notice, which is always the final word. Recall Relay isn't affiliated with any agency or with the companies named here.
Severity labels say where they come from: “official” is the agency's own class, “advisory” is based on the agency's safety warning, and “est. risk” is Recall Relay's estimate from the hazard description, not an agency classification.
Hear about the next one
Recall Relay can email you when a new recall mentions Apotex Corp. or any words you choose. Start with a free key (no card needed), then set up alerts on your account page.
Get recall alerts